// App-Quantinova.ai

TCT-425 : Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry

Researchers

Presenter

  • Giulia Masiero

Principal Investigators

  • Giuseppe Tarantini

  • Marco Mojoli

  • Alessandro Durante

  • Bruno Loi

  • Bernardo Cortese

  • Attilio Varricchio

  • Alfonso Ielasi

  • Francesco Pisano

  • Pietro Mazzarotto

  • Paolo Calabr-

  • Roberto Gistri

Medical Centers

  • Interventional Cardiology, Ospedale Maggiore, Lodi, Italy

  • USD Emodinamica, A.S.O. S. Croce e Carle, Cuneo, Italy

  • Interventional Cardiology, A.O. Monaldi, Naples, Italy

  • Interventional Cardiology, SS. Filippo e Nicola Hospital, Avezzano, Italy

  • spezzino, la spezia, La Spezia, Italy

  • Cardiovascular Intervention Unit, San Martino Hospital, Belluno, Italy, Italy

  • Second University of Naples, Naples, Italy

  • Fatebenefratelli Hospital, Milano, Milan, Italy

  • Luigi Sacco Hospital, Milano, Italy

  • Ospedale San Paolo, Savona, Italy

  • Biostatistics, Epidemiology and Public Health Unit of Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy

  • Cardiology Division, A.O. Bolognini, Seriate, Italy

  • Padua South Hospital, MONSELICE, Padua, Italy

  • Mario Negri Research Institute, Milan, Italy

  • Cardinal Massaja Hospital, Asti, Italy

  • Ospedale Manzoni, Lecco, Lecco, Italy

  • Ospedale Ca Foncello, Treviso, Treviso, Italy

  • Interventional Cardiology, Parini Regional Hospital, Aosta, Italy

  • Azienda Ospedaliera Brotzu, Cagliari, Italy

  • Division of Cardiology, Mazzoni Hospital, Ascoli Piceno, Italy

  • University of Padova, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy

  • Cardiology Division, Policlinico S. Matteo, Pavia, Italy

  • Cardiology Division, Valduce Hospital, Como, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim